Two distinct mechanisms are described, which includehypercalcemia by local osteolytic lesions (bone metastasis) and humoralhypercalcemia by the activation of RANK-RANKL (receptor activator of nuclearfactor κB and its ligand). The gene discussed is TNFSF11; the disease is bone metastasis.